Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check5 days agoChange DetectedAdded new MedlinePlus Genetics topic: Melanoma.SummaryDifference0.2%
- Check12 days agoChange DetectedSummary: Added a government operating-status notice and new version v3.2.0; removed MedlinePlus Genetics topic Melanoma and old version v3.1.0.SummaryDifference3%
- Check19 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check26 days agoChange DetectedAdded a MedlinePlus Genetics topic on Melanoma; no deletions observed.SummaryDifference0.2%
- Check33 days agoChange DetectedAdded Revision: v3.0.2 and removed the older v3.0.1 entry, the MedlinePlus Genetics 'Melanoma' topic, and the 'Back to Top' link.SummaryDifference0.4%
- Check41 days agoChange DetectedThe web page has been updated to include information on Melanoma under MedlinePlus Genetics topics, and the revision number has changed from v3.0.0 to v3.0.1.SummaryDifference0.4%
Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.